scispace - formally typeset
J

Jorge Gallego

Researcher at French Institute of Health and Medical Research

Publications -  132
Citations -  4871

Jorge Gallego is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Congenital central hypoventilation syndrome & Hypercapnia. The author has an hindex of 38, co-authored 125 publications receiving 4538 citations. Previous affiliations of Jorge Gallego include University of Paris & Paris Diderot University.

Papers
More filters
Journal ArticleDOI

Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism

TL;DR: It is reported that mice with a loss-of-function mutation in the murine NLGN4 ortholog Nlgn4, which encodes the synaptic cell adhesion protein Neuroligin-4, exhibit highly selective deficits in reciprocal social interactions and communication that are reminiscent of ASCs in humans.
Journal ArticleDOI

Phox2b controls the development of peripheral chemoreceptors and afferent visceral pathways

TL;DR: It is reported that the afferent relays of visceral reflexes, differentiate under the control of the paired-like homeobox gene Phox2b: the neural crest-derived carotid body, a chemosensor organ, degenerates in homozygous mutants, as do the three epibranchial placode-derived visceral sensory ganglia (geniculate, petrosal and nodose).
Journal ArticleDOI

A human mutation in Phox2b causes lack of CO2 chemosensitivity, fatal central apnea, and specific loss of parafacial neurons

TL;DR: It is shown that mice bearing a mutation in Phox2b that causes congenital central hypoventilation syndrome in humans breathe irregularly, do not respond to an increase in CO2, and die soon after birth from central apnea.
Journal ArticleDOI

VGLUT3 (Vesicular Glutamate Transporter Type 3) Contribution to the Regulation of Serotonergic Transmission and Anxiety

TL;DR: It is found that deletion of VGLUT3 increased several anxiety-related behaviors in adult and in newborn mice as early as 8 d after birth and the results suggest that the loss of V GLUT3 expression leads to anxiety-associated behaviors and should be considered as a potential new target for the treatment of this disorder.